Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
29.25
-0.97 (-3.21%)
At close: Mar 11, 2025, 4:00 PM
29.80
+0.55 (1.88%)
After-hours: Mar 11, 2025, 6:05 PM EST
Janux Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,729 | 3,087 | 495 | 547 | 821 | - | |
| Market Cap Growth | 523.34% | 523.34% | -9.51% | -33.35% | - | - | |
| Enterprise Value | 727 | 2,452 | 170 | 233 | 434 | - | |
| Last Close Price | 29.25 | 53.54 | 10.73 | 13.17 | 19.73 | - | |
| PS Ratio | 148.49 | 291.54 | 61.26 | 63.54 | 225.73 | - | |
| PB Ratio | 1.69 | 3.02 | 1.44 | 1.71 | 2.24 | - | |
| P/TBV Ratio | 3.02 | 3.02 | 1.44 | 1.71 | 2.24 | - | |
| EV/Sales Ratio | 68.63 | 231.60 | 21.08 | 27.00 | 119.25 | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.07 | 0.08 | 0.00 | - | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | - | |
| Quick Ratio | 59.03 | 59.03 | 26.56 | 19.85 | 29.32 | 4.97 | |
| Current Ratio | 59.21 | 59.21 | 26.80 | 20.14 | 29.46 | 5.05 | |
| Return on Equity (ROE) | -10.09% | -10.09% | -17.53% | -18.36% | -17.50% | -446.61% | |
| Return on Assets (ROA) | -8.57% | -8.57% | -12.25% | -11.27% | -10.39% | -35.83% | |
| Return on Capital (ROIC) | -8.73% | -8.73% | -12.76% | -11.77% | -11.02% | -86.02% | |
| Earnings Yield | -3.99% | -2.24% | -11.77% | -11.52% | -3.98% | - | |
| FCF Yield | -2.56% | -1.43% | -10.59% | -9.02% | -2.25% | - | |
| Buyback Yield / Dilution | -22.12% | -22.12% | -6.14% | -76.24% | -2471.20% | -36.71% | |
| Total Shareholder Return | -22.12% | -22.12% | -6.14% | -76.24% | -2471.20% | -36.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.